Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Far Biotech STAT3 inhibitor
- Development stage
- Preclinical
- Lead developer
- Far Biotech
- Modality
- Small Molecules
01
Overview
Far Biotech's STAT3 inhibitor is a preclinical-stage small molecule candidate discovered using the company's proprietary Quantum AI platform. It is designed to target and inhibit the Signal Transducer and Activator of Transcription 3 (STAT3) protein, a transcription factor that is often constitutively active in many types of cancer. Overactive STAT3 signaling is associated with tumor cell proliferation, apoptosis resistance, angiogenesis, and suppression of the antitumor immune response. By blocking STAT3 activity, this drug candidate aims to inhibit tumor growth and potentially enhance immune recognition of cancer cells. The development program is currently in the preclinical phase, with Aragen serving as a research partner.
- Other names
- STAT3 inhibitor (structurally novel leads)Far Biotech STAT3 small molecule
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on Far Biotech STAT3 inhibitor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Far Biotech STAT3 inhibitor.